Metraipolis › archive › dc_ecf351ea9593

Trends in diagnostic testing in Medicare patients with wild-type transthyretin amyloid cardiomyopathy — Europe PMC PMID:41235331

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41235331
DOI
10.3389/fcvm.2025.1638380
License (as archived)
solo-consultazione
Archived
2026-11-08T23:24:12.185Z
SHA-256 of the archived text
529479eb80080203d6f623defafb2496d569d6de3e76e63bb84ea5b25e1b86e1
Stable URL of this page
https://metraipolis.com/documento/dc_ecf351ea9593

How to cite

Trends in diagnostic testing in Medicare patients with wild-type transthyretin amyloid cardiomyopathy — Europe PMC PMID:41235331 — Europe PMC (en), https://europepmc.org/article/MED/41235331 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ecf351ea9593 (Metraipolis archive dc_ecf351ea9593, sha256 529479eb80080203d6f623defafb2496d569d6de3e76e63bb84ea5b25e1b86e1)
BibTeX
@misc{dcecf351ea9593,
  title = {Trends in diagnostic testing in Medicare patients with wild-type transthyretin amyloid cardiomyopathy — Europe PMC PMID:41235331},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41235331},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ecf351ea9593; sha256 529479eb80080203d6f623defafb2496d569d6de3e76e63bb84ea5b25e1b86e1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41235331. Agents can read the archived copy with the MCP tool read_document.